A federal judge in Boston this week lifted the bail and travel restrictions imposed on a pair of former Acclarent executives who were acquitted of felony fraud charges in July. Former CEO William Facteau and ex-sales vice president Patrick Fabian were convicted on 10 misdemeanor counts of “introducing adulterated and misbranded medical devices into interstate commerce.” Facteau is […]
Acclarent Inc.
Acclarent launches Relieva Scout multi-sinus dilator
Johnson & Johnson (NYSE:JNJ) subsidiary Acclarent said Wednesday it is launching the Relieva Scout multi-sinus dilation system in the U.S. The Relieva Scout is designed to use balloon sinuplasty technology to confirm and dilate sinus openings in individuals with chronic sinusitis through a minimally-invasive procedure. “I’m always looking for new technologies that enable me to […]
J&J’s Acclarent to pay $18m over off-label marketing charges
Johnson & Johnson (NYSE:JNJ) subsidiary Acclarent will pay $18 million to resolve allegations over false claims submitted to Medicare and other federal health care programs in relation to marketing its Relieva Stratus MicroFlow sinus spacer as a drug-delivery device without FDA clearance. The company won FDA clearance in 2006 to market the Stratus as a […]
Ex-Acclarent CEO, sales VP escape felony charges, convicted on misdemeanors
UPDATED July 21, 2016, with verdict details, comment from defense lawyers. A federal jury today convicted 2 former Acclarent executives for the distribution of adulterated and misbranded medical devices, but acquitted them of the felony charges leveled in the case. Former CEO William Facteau and ex-sales vice president Patrick Fabian were convicted by a jury after […]
Could pharma exec’s acquittal help accused ex-Acclarent officials?
The acquittal last week of a former pharmaceutical executive, charged in a kickbacks scheme to win business from doctors, could prove a boon for a pair of medical device executives facing similar charges. A jury in Massachusetts federal court cleared former Warner Chilcott pharmaceutical president Carl Reichel of charges that he coach sales reps to woo doctors by taking them to expensive […]
Feds indict ex-Acclarent execs | The week in medtech M&A
Feds slap former Acclarent execs with fraud charges
Federal prosecutors last week leveled conspiracy and fraud charges against 2 former executives of Acclarent for an alleged off-label marketing scheme for the Relieva Stratus microflow spacer.
Medtronic wins Canadian approval for brain-stim therapy for epileptics | Regulatory Roundup
Legal roundup: Zimmer sues law firms; Entellus, Acclarent settle; Covidien workers seek class action
Zimmer Holdings Inc. (NYSE:ZMH) filed a lawsuit against three law firms waging an advertising campaign against the company’s NexGen knee replacement system.
The Warsaw, Ind.-based artificial knee maker is seeking an injunction for the Internet and television-based advertisements proclaiming that the implant “has a high failure rate, causes pain and is otherwise defective,” according to documents filed Feb. 16 with the U.S. District Court for the Northern Indiana.